2737
Flutamide withdrawal syndrome is characterized by a decrease in prostate-specific antigen (PSA) after flutamide withdrawal in a subset of patients with progressing metastatic carcinoma of the prostate.
 subset of patients with progressing metastatic carcinoma of the prostate: Subject; decrease in prostate-specific antigen (PSA): Effect; flutamide: Treatment; progressing metastatic carcinoma of the prostate: Treatment.Disorder; flutamide: Treatment.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 subset of patients with progressing metastatic carcinoma of the prostate: Subject; decrease in prostate-specific antigen (PSA): Effect; flutamide: Treatment; progressing metastatic carcinoma of the prostate: Treatment.Disorder; flutamide: Treatment.Drug